Correction: Pre-targeted delivery of a tetrazinylated albumin–zinc( ii ) porphyrin complex for tumor photodynamic therapy

Key Points

• The aim is to correct previously published findings related to the delivery mechanism and efficacy of a specific drug complex in tumor treatment.
• Correction of previous findings, which involved the use of tetrazinylated albumin-zinc porphyrin complex in photodynamic therapy.
• Focus on the delivery mechanism and how it affects treatment results in tumors.
• Correction acknowledged advancements in targeted drug delivery.
• Improvements in therapeutic efficacy noted but specific numerical results not provided in correction.